201 related articles for article (PubMed ID: 29947170)
1. Effectiveness of temozolomide combined with whole brain radiotherapy for non-small cell lung cancer brain metastases.
Zhu Y; Fu L; Jing W; Guo D; Kong L; Yu J
Thorac Cancer; 2018 Sep; 9(9):1121-1128. PubMed ID: 29947170
[TBL] [Abstract][Full Text] [Related]
2. The efficacy and roles of combining temozolomide with whole brain radiotherapy in protection neurocognitive function and improvement quality of life of non-small-cell lung cancer patients with brain metastases.
Deng X; Zheng Z; Lin B; Su H; Chen H; Fei S; Fei Z; Zhao L; Jin X; Xie CY
BMC Cancer; 2017 Jan; 17(1):42. PubMed ID: 28068937
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of whole-brain radiotherapy plus temozolomide compared with whole-brain radiotherapy for the treatment of brain metastases from non-small-cell lung cancer.
Xin Y; Guo W; Yang CS; Huang Q; Zhang P; Zhang LZ; Jiang G
Cancer Med; 2018 Apr; 7(4):981-990. PubMed ID: 29516684
[TBL] [Abstract][Full Text] [Related]
4. Combined treatment for non-small cell lung cancer and breast cancer patients with brain metastases with whole brain radiotherapy and temozolomide: a systematic review and meta-analysis.
Tian J; Luo Y; Xiang J; Tang J
J Neurooncol; 2017 Nov; 135(2):217-227. PubMed ID: 28726172
[TBL] [Abstract][Full Text] [Related]
5. Response and safety of whole-brain radiotherapy plus temozolomide for patients with brain metastases of non-small-cell lung cancer: A meta-analysis.
Han J; Qiu M; Su L; Wu C; Cheng S; Zhao Z; Li D; Wang M; Tao W; Du S
Thorac Cancer; 2021 Dec; 12(23):3177-3183. PubMed ID: 34704360
[TBL] [Abstract][Full Text] [Related]
6. Phase II Study of the Efficacy and Safety of High-dose Pemetrexed in Combination with Cisplatin
He Q; Bi X; Ren C; Wang Y; Zou P; Zhang H; Chi N; Xiu C; Wang Y; Tao R
Anticancer Res; 2017 Aug; 37(8):4711-4716. PubMed ID: 28739776
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of synchronous stereotactic radiotherapy with temozolomide combined with whole brain radiotherapy in treating brain metastases originating from non-small cell lung cancer.
Liu P; Ren R; You D; Liu J
J BUON; 2020; 25(4):1771-1778. PubMed ID: 33099912
[TBL] [Abstract][Full Text] [Related]
8. Whole-brain radiation therapy plus concomitant temozolomide for the treatment of brain metastases from non-small-cell lung cancer: a randomized, open-label phase II study.
Chua D; Krzakowski M; Chouaid C; Pallotta MG; Martinez JI; Gottfried M; Curran W; Throuvalas N
Clin Lung Cancer; 2010 May; 11(3):176-81. PubMed ID: 20439193
[TBL] [Abstract][Full Text] [Related]
9. A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320.
Sperduto PW; Wang M; Robins HI; Schell MC; Werner-Wasik M; Komaki R; Souhami L; Buyyounouski MK; Khuntia D; Demas W; Shah SA; Nedzi LA; Perry G; Suh JH; Mehta MP
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1312-8. PubMed ID: 23391814
[TBL] [Abstract][Full Text] [Related]
10. Phase II randomized study of whole-brain radiation therapy with or without concurrent temozolomide for brain metastases from breast cancer.
Cao KI; Lebas N; Gerber S; Levy C; Le Scodan R; Bourgier C; Pierga JY; Gobillion A; Savignoni A; Kirova YM
Ann Oncol; 2015 Jan; 26(1):89-94. PubMed ID: 25355723
[TBL] [Abstract][Full Text] [Related]
11. Temozolomide plus whole brain radiotherapy for the treatment of non-small-cell lung cancer patients with brain metastases: A protocol of an updated systematic review and meta-analysis.
Duan H; Zheng SY; Zhou T; Cui HJ; Hu KW
Medicine (Baltimore); 2020 Jan; 99(5):e18455. PubMed ID: 32000358
[TBL] [Abstract][Full Text] [Related]
12. [Whole brain radiation therapy plus temozolomide in the treatment of brain metastases from non small cell lung cancer: a meta-analysis].
Liao K; Bi ZF; He Y; Liu YM
Zhonghua Yi Xue Za Zhi; 2012 Dec; 92(45):3199-203. PubMed ID: 23328466
[TBL] [Abstract][Full Text] [Related]
13. Brain metastases from melanoma: is there a role for concurrent temozolomide in addition to whole brain radiation therapy?
Schild SE; Behl D; Markovic SN; Brown PD; Sande JR; Deming RL; Rowland KM; Bearden JD
Am J Clin Oncol; 2010 Dec; 33(6):633-6. PubMed ID: 20042969
[TBL] [Abstract][Full Text] [Related]
14. Brain Radiotherapy plus Concurrent Temozolomide versus Radiotherapy Alone for Patients with Brain Metastases: A Meta-Analysis.
Zhao Q; Qin Q; Sun J; Han D; Wang Z; Teng J; Li B
PLoS One; 2016; 11(3):e0150419. PubMed ID: 26930609
[TBL] [Abstract][Full Text] [Related]
15. Whole brain radiation therapy followed by intensity-modulated boosting treatment combined with concomitant temozolomide for brain metastases from non-small-cell lung cancer.
Wang Q; Jiang Z; Qi X; Lu S; Wang S; Leng C; Lu F; Liu H; Liang S; Shi J
Clin Transl Oncol; 2014 Nov; 16(11):1000-5. PubMed ID: 24894840
[TBL] [Abstract][Full Text] [Related]
16. Gefitinib alone or with concomitant whole brain radiotherapy for patients with brain metastasis from non-small-cell lung cancer: a retrospective study.
Zeng YD; Zhang L; Liao H; Liang Y; Xu F; Liu JL; Dinglin XX; Chen LK
Asian Pac J Cancer Prev; 2012; 13(3):909-14. PubMed ID: 22631670
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effectiveness of whole-brain radiotherapy plus temozolomide versus whole-brain radiotherapy in treating brain metastases based on a systematic review of randomized controlled trials.
Bai GR; An JB; Chu Y; Wang XY; Li SM; Yan KJ; Lü FR; Gu N; Griffin AN; Sun BY; Li W; Wang GC; Zhou SP; Sun H; Liu CX
Anticancer Drugs; 2016 Jan; 27(1):1-8. PubMed ID: 26426520
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of whole brain radiotherapy with or without erlotinib in patients with multiple brain metastases from lung adenocarcinoma.
Zhuang H; Yuan Z; Wang J; Zhao L; Pang Q; Wang P
Drug Des Devel Ther; 2013; 7():1179-86. PubMed ID: 24133369
[TBL] [Abstract][Full Text] [Related]
19. Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03).
Pesce GA; Klingbiel D; Ribi K; Zouhair A; von Moos R; Schlaeppi M; Caspar CB; Fischer N; Anchisi S; Peters S; Cathomas R; Bernhard J; Kotrubczik NM; D'Addario G; Pilop C; Weber DC; Bodis S; Pless M; Mayer M; Stupp R
Eur J Cancer; 2012 Feb; 48(3):377-84. PubMed ID: 22093943
[TBL] [Abstract][Full Text] [Related]
20. Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial.
Verger E; Gil M; Yaya R; Viñolas N; Villà S; Pujol T; Quintó L; Graus F
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):185-91. PubMed ID: 15629610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
